Saranjeet Kaur

Learn More
For the present study, two polymorphisms, xeroderma pigmentosum, complementation group D (XPD) Lys751Gln and RAD51 135G/C were studied with regard to bladder cancer. For XPD Lys751Gln polymorphism, an increased risk of bladder cancer was found to be associated with the Gln variant allele (odds ratio [OR]=1.86, 95% confidence interval [CI]=1.27-2.73), on(More)
The aim of the study was to investigate genetic polymorphism in apoptotic gene, BCL-2 (C938A), and the risk of bladder cancer through a hospital-based case-control study. This retrospective analysis consisted of 270 cases of bladder cancer and 252 controls. The BCL-2 938 AA genotype showed a decreased risk of bladder cancer among smokers (OR = 0.40, 95% CI(More)
  • 1